Murli Krishna Pharma Private Ltd. is a 20-year-old Indian organization that provides a range of innovative solutions to optimize the delivery of pharmaceutical preparations. We manufacture Pre-Finished Formulation Intermediates and Finished Dosage forms in our plant that is approved by the European Union, WHO, GCC and Jordanian FDA.

Our PFI product range is in the form of Pellets & Micro Pellets. Finished Dosage Forms are manufactured employing Micro and Nano emulsions. The formulations developed are in the form of Oral Solid dosage, Injectable, Ophthalmic Preparations and Transdermal Lotions.

Murli Krishna Pharma pioneered the introduction of Transdermal Lotion as a branded formulation that caters to treating Anaemia through a metered dose administration. This is a platform technology and will be extended for administering calcium, folate, B12 and D3. We have also developed soft administered Nano Emulsions of Corticosteroids, using patent non-infringing device.

Murli Krishna Pharma also renders Contract Research and Manufacturing Services (CRAMS), and has successfully undertaken Contract Research Projects from US and European organisations.